A category of substances called pharmaceuticals and personal care products (PPCPs) is routinely detected in our nation’s ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

Regeneron signs $3 billion deal with FUJIFILM to expand biologics manufacturing in North Carolina, boosting U.S. capacity and ...

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.

For FTSE 100 businesses navigating the shifting sands of Trump’s trade war, the uncertainty surrounding the tariffs has been ...

Regeneron Pharmaceuticals Inc. agreed to pay Fujifilm Diosynth Biotechnologies more than $3 billion over the next decade to ...

Not only are pharmaceutical stocks excellent defensive investments, some pharma stocks pay sizable dividends that can be a ...

FDA accepts Regeneron's sBLA for Eylea HD in RVO with priority review; QUASAR data supports monthly dosing, target action date set for August 2025.

Intimation for the closure of Trading window as per SEBI PIT Regulations, trading window for dealing in securities will be closed for all the officers... Intimation regarding appointment of ...

Regeneron's oncology platform is poised to be a significant growth driver in the next decade. Read why REGN stock remains a ...